Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Host Response and Inflammation

Quantitative Comparison of Active and Latent Tuberculosis in the Cynomolgus Macaque Model

Philana Ling Lin, Mark Rodgers, Le'kneitah Smith, Matthew Bigbee, Amy Myers, Carolyn Bigbee, Ion Chiosea, Saverio V. Capuano, Carl Fuhrman, Edwin Klein, JoAnne L. Flynn
Philana Ling Lin
1Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15224
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Rodgers
2Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Le'kneitah Smith
2Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Bigbee
2Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy Myers
2Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolyn Bigbee
2Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ion Chiosea
2Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saverio V. Capuano
2Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261
5Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carl Fuhrman
3Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15261
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edwin Klein
4Division of Laboratory Animal Resources, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JoAnne L. Flynn
2Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: joanne@pitt.edu
DOI: 10.1128/IAI.00592-09
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Greater production of IFN-γ in response to CFP-10 is seen in PBMC at 6 weeks postinfection among monkeys who will develop active disease. Mycobacterium-specific IFN-γ production was measured in PBMC by the ELISPOT assay of monkeys who later would be classified as having active tuberculosis or latent infection. No difference in the production of IFN-γ was seen in PBMC stimulated with ESAT-6 peptide or CFP. ELISPOT assay results were measured in spot-forming units (SFU) per 200,000 cells. **, P < 0.01 by Mann-Whitney test; n = 38 for latently infected monkeys; n = 36 for active-disease monkeys.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Monkeys who develop active disease have a higher frequency of mycobacterium-specific IFN-γ-producing T cells in BAL cells during the first 2 months after M. tuberculosis infection. The ELISPOT assay was used to measured IFN-γ production in response to ESAT-6 and CFP-10 peptides at preinfection and at 1, 2, and 6 months postinfection. Monkeys who later would develop active disease had greater production of IFN-γ to ESAT-6 at 1 month postinfection and greater response to CFP-10 at 2 months postinfection than did those that would present with latent infection. No differences were observed at baseline or at 6 months postinfection. *, P < 0.05 by Mann-Whitney test. The measurement of IFN-γ by ELISPOT assay was quantified in spot-forming units (SFU) per 100,000 cells. n = 24 to 29 for latently infected monkeys; n = 16 to 24 for active-disease monkeys.

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Active-disease monkeys have more gross pathology at necropsy than latently infected monkeys. The cartoon depiction of the gross disease demonstrates the presence of enlarged lymph nodes (gray circles), granulomatous lymph nodes (checkered circles), and granulomas (black circles) in the lungs, lymph nodes, and extrapulmonary sites (liver and spleen). Cavitary disease is represented by a thick circle (upper lobe of 6804). Monkeys with active disease demonstrate a wide spectrum of disease involvement that includes the lung and thoracic lymph nodes and also can involve liver and spleen (e.g., 9903). Tuberculous pneumonia is observed to occur in the lungs of some active-disease monkeys (white dotted pattern on black in lung lobes), such as in the bilateral upper and lower lobes of 10403. In contrast, latently infected monkeys have limited disease consisting of, at a minimum, lymph node involvement and sometimes the granuloma involvement of the lung. No extrapulmonary disease is seen in latent infection. Subclinical percolating monkeys had disease that was limited to the lung and lymph node in the same pattern as that of latently infected monkeys, with one exception (18305). Monkeys who had latent infection and developed spontaneous reactivation are indicated by an asterisk.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Monkeys with active disease have higher ESRs, necropsy scores, bacterial burdens, and dissemination than latently infected and subclinical percolator monkeys. The necropsy score is based on the size and frequency of tuberculous lesions in the lung, mediastinal lymph nodes, and abdominal viscera prospectively identified at the time of necropsy. Bacterial burden is measured first by the CFU score, which is derived by the sum of the log-transformed CFU per gram of tissue plated at the time of necropsy as a method of measuring the overall bacterial burden and by the summation of CFU per gram of tissue for all samples (Total CFU). The distribution of bacterial growth (dissemination) is measured by calculating the overall percentage of samples in which M. tuberculosis was detected at necropsy. ESR and percent-positive samples were analyzed by ANOVA with Bonferroni's post hoc analysis, whereas all other parameters were measured by Kruskal-Wallis with Dunn's multiple-comparison post hoc analysis. *, P < 0.05; **, P < 0.01; ***, P < 0.001; n = 16 for active-disease monkeys, 8 for latently infected monkeys, 5 for percolator monkeys, and 2 for reactivator monkeys.

  • FIG. 5.
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    Microscopic histopathology of tuberculosis in the cynomolgus macaque model demonstrates a spectrum of lesion types. (A) The hilar lymph node of a latently infected monkey demonstrates the complete effacement of nodal architecture, which is replaced by mineralized material (magnification, ×5; hematoxylin and eosin staining [H&E] was used). (B) A sclerotic granuloma, characterized by centrally located sclerotic collagenous material with scant cellular components, from the lung of a latently infected monkey (magnification, ×10; H&E). (C) A mineralized granuloma from the lung of a latently infected monkey. Mineral is noted in the center of the granuloma (resulting in artifactual shattering of material), surrounded by a periphery of lymphoplasmacytic cells (magnification, ×10; H&E). (D) A multifocal pattern of both caseous and nonnecrotizing granulomas infiltrating the architecture of a hilar/mediastinal lymph node from an active-disease monkey (magnification, ×2; H&E). (E) A well-circumscribed nonnecrotic (solid cellular) granuloma consisting of centrally located epithelioid macrophages and peripheral lymphocytes from the right lower lobe of an active-disease monkey (magnification, ×5; H&E). (F) A caseous granuloma consisting of a central area of amorphous eosinophilic caseum surrounded by a mantle of pallisading epithelioid macrophages and peripherally located lymphocytic cuff from an active-disease monkey (magnification, ×5; H&E). (G) Tuberculous pneumonia in the lung of an active-disease monkey in which both caseous and nonnecrotizing granulomas are seen with surrounding inflammatory cells (macrophages, neutrophils, and lymphocytes) invading into the alveolar lung structures (magnification, ×10; H&E).

  • FIG. 6.
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    Greater IFN-γ production in response to ESAT-6 and CFP-10 peptides in active-disease monkeys in the PBMC, BAL cells, and hilar lymph node cells at necropsy. Spot-forming units in this figure represent the summation of responses to peptide pools of ESAT-6 and CFP-10. Too few lung samples with sufficient T cells were obtained from latently infected monkeys to allow statistical analyses. Subclinical percolating monkeys had results that were similar to those of latently infected monkeys, suggesting that they exhibit a spectrum of latent infection. ELISPOT assay results are shown as spot-forming units (SFU). *, P < 0.05; **, P < 0.01; ***, P < 0.001 (all by Mann-Whitney test).

  • FIG. 7.
    • Open in new tab
    • Download powerpoint
    FIG. 7.

    Higher production of certain cytokines and chemokines in the lungs of active-disease monkeys than in those of latently infected monkeys. Cytokine and chemokine levels were determined by a Luminex analysis of tissue homogenates. TNF production appeared to be greater in the lungs of active-disease monkeys, although this did not reach statistical significance (P = 0.067). *, P < 0.05; **, P < 0.01; ***, P < 0.001 (all by Mann-Whitney test).

Tables

  • Figures
  • Additional Files
  • TABLE 1.

    Multivariate logistic regression analysis of variables prior to or in the first 8 weeks of infection compared to results from clinical outcomesa (active disease and latent infection)

    VariableInfection typeOdds ratio (95% CI)P value
    ActiveLatent
    Age (yr)7.88 ± 1.778.22 ± 1.391.05 (0.69-1.62)0.80
    GA (% positive)57.116.210.81 (2.09-55.96)0.005
    ESR (mm)5.19 ± 8.812.22 ± 4.881.09 (0.90-1.32)0.39
    Weight (kg)6.72 ± 1.467.15 ± 1.630.79 (0.49-1.25)0.31
    LPA (fold increase from baseline)10.15 ± 10.8817.76 ± 39.60.99 (0.97-1.02)0.75
    Gender (male:female)33:431:60.39 (0.039-3.78)0.42
    TST (score)3.94 ± 0.763.66 ± 0.711.09 (0.89-1.33)0.39
    • ↵ a Age and weight were measured at the time of infection; GA indicates the GA for M. tuberculosis growth in the first 60 days of infection; ESR indicates the peak ESR in the first 60 days of infection; LPA indicates the lymphocyte proliferation assay of PBMC in response to CFP at 6 weeks postinfection compared to values from the preinfection LPA; and TST indicates the peak TST score in the first 60 days of infection (scoring range, 0 to 5). CI, confidence interval.

  • TABLE 2.

    Numbers of CD4 and CD8 T cells in granulomatous lung and lymph node tissue compared to those of monkeys with latent or subclinical percolating diseasea

    Infection typeNo. of cells/g (log transformed; means ± SD) from:
    Hilar lymph nodeLung granuloma
    CD4CD8CD4CD8
    Active7.86 ± 1.147.46 ± 1.186.5 ± 0.816.60 ± 0.86
    Latent7.40 ± 1.257.37 ± 0.834.60 ± 0.94**4.98 ± 0.76**
    Percolator7.81 ± 0.737.95 ± 1.204.76 ± 0.80*4.81 ± 0.75*
    • ↵ a Results were analyzed by ANOVA (P = 0.0001) and Bonferroni's multiple-comparison test (* and **, P <.01 and P <.001 compared to results for active granulomas). All other values were not significantly different by ANOVA or in post hoc analysis.

Additional Files

  • Figures
  • Tables
  • Supplemental material

    Files in this Data Supplement:

    • Supplemental file 1 - Gross-pathology scoring system for tuberculosis infection of nonhuman primates.
      MS Word document, 70K.
PreviousNext
Back to top
Download PDF
Citation Tools
Quantitative Comparison of Active and Latent Tuberculosis in the Cynomolgus Macaque Model
Philana Ling Lin, Mark Rodgers, Le'kneitah Smith, Matthew Bigbee, Amy Myers, Carolyn Bigbee, Ion Chiosea, Saverio V. Capuano, Carl Fuhrman, Edwin Klein, JoAnne L. Flynn
Infection and Immunity Sep 2009, 77 (10) 4631-4642; DOI: 10.1128/IAI.00592-09

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Infection and Immunity article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Quantitative Comparison of Active and Latent Tuberculosis in the Cynomolgus Macaque Model
(Your Name) has forwarded a page to you from Infection and Immunity
(Your Name) thought you would be interested in this article in Infection and Immunity.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Quantitative Comparison of Active and Latent Tuberculosis in the Cynomolgus Macaque Model
Philana Ling Lin, Mark Rodgers, Le'kneitah Smith, Matthew Bigbee, Amy Myers, Carolyn Bigbee, Ion Chiosea, Saverio V. Capuano, Carl Fuhrman, Edwin Klein, JoAnne L. Flynn
Infection and Immunity Sep 2009, 77 (10) 4631-4642; DOI: 10.1128/IAI.00592-09
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Mycobacterium tuberculosis
tuberculosis

Related Articles

Cited By...

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522